¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"primary visual cortex"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • primary insanity
    ÀÏÂ÷Á¤½ÅÀÌ»ó, ¿ø¹ß¼ºÁ¤½ÅÀÌ»ó
  • primary interaction
    ÀÏÂ÷»óÈ£ÀÛ¿ë
  • primary irritant dermatitis
    ¿ø¹ßÀÚ±ØÇǺο°
  • primary irritation
    ÀÏÂ÷ÀÚ±Ø
  • primary lateral sclerosis
    ¿ø¹ß°¡ÂʰæÈ­Áõ, ¿ø¹ßÃø»è°æÈ­Áõ
  • primary lesion
    ÀÏÂ÷º´ÅÍ
  • primary lysosome
    ÀÏÂ÷¿ëÇØ¼Òü
  • primary membrane bone
    ÀÏÂ÷¸·»À, ¼¼¸Á¼¶À¯¸·»À
  • primary mover
    ÁÖÀÛ¿ë±Ù
  • primary olfactory receiving area
    ÀÏÂ÷Èİ¢¿µ¿ª
  • primary oocyte
    ÀÏÂ÷³­¸ð¼¼Æ÷
  • primary organizer
    ÀÏÂ÷Çü¼ºÃ¼
  • primary ossification center
    ÀÏÂ÷»ÀµÇ±âÁß½É, ÀÏÂ÷°ñÈ­Áß½É
  • primary pigmented nodular adrenocortical disease
    ¿ø¹ß»ö¼ÒÄ§Âø°áÀýºÎ½Å°ÑÁúº´, ¿ø¹ß»ö¼ÒÄ§Âø°áÀýºÎ½ÅÇÇÁúº´
  • primary polydipsia
    ¿ø¹ß´ÙÀ½Áõ, ¿ø¹ß´ÙÀ½´Ù°¥Áõ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • primary integration
    ¼Ò¾ÆÀÏÂ÷¼ºÀÚ±âÀνÄ
  • primary interaction
    ÀÏÂ÷»óÈ£ÀÛ¿ë
  • primary irritation
    ÀÏÂ÷ÀÚ±Ø
  • primary lesion
    ÀÏÂ÷º´ÅÍ
  • primary mover
    ÁÖÀÛ¿ë±Ù
  • primary mycelium
    ÀÏÂ÷±Õ»çü
  • primary amebic meningoencephalitis
    ¿ø¹ß¾Æ¸Þ¹Ù¼ö¸·³ú¿°
  • occult primary tumor
    Àẹ¿ø¹ßÁ¾¾ç
  • primary oocyte
    ÀÏÂ÷³­¸ð¼¼Æ÷
  • primary organizer
    ÀÏÂ÷Á¶¼ºÀÚ
  • primary
    ¿ø¹ß¼º-, ÀÏÂ÷Àû-
  • primary brain vesicles
    ÀÏÂ÷³úÆ÷
  • primary sensation
    ÀÏÂ÷°¨°¢
  • primary sequestrum
    ¿ÏÀüºÐ¸®Á×Àº»À, ÃʱâºÎ°ñ, Á¦ÀϱâºÎ°ñ
  • primary sporocyst
    ÀÏÂ÷Æ÷ÀÚ³¶
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • primary immunodeficiency
    ¿ø¹ß¼º ¸é¿ª°áÇÌ
  • primary immunodeficiency syndrome
    ¿ø¹ß¼º ¸é¿ª°áÇÌ ÁõÈıº
  • primary impression
    ÀÏÂ÷Àλó(¡­ìÔßÚ).
  • primary inclusion
    ÀÏÂ÷ºÀÀÔü(ÀÏÂ÷ºÀÀÔü).
  • primary infection
    ÀÏÂ÷°¨¿°
  • primary infiltration
    ÃʱâħÀ±
  • primary inoculation complex
    ¿ø¹ß¼º Á¢Á¾ º¹ÇÕü
  • primary insanity
    ¿ø¹ß(¼º) Á¤½Åº´(ê«Û¡àõïñãêÜ»).
  • primary insomnia
    ÀÏÂ÷¼º¡¡ºÒ¸éÁõ
  • primary integration
    ¼Ò¾ÆÀÏÂ÷¼º ÀÚ±âÀνÄ(á³ä®ìéó­àõí»ÐùìããÛ).
  • primary ionization
    ÀÏÂ÷ÀÌ¿ÂÈ­.
  • primary irritation
    ÀÏÂ÷ÀÚ±Ø(¡­ô§Ð½).
  • primary lateral sclerosis
    ¿ø¹ß(¼º) Ãø»è°æÈ­(Áõ)(¡­ö°ßãÌãûùñø).
  • primary lateral sclerosis
    ¿ø¹ß(¼º) Ãø»è°æÈ­(Áõ)(ê«Û¡(àõ) ö°ßãÌãûùñø)
  • primary lens fiber
    ÀÏÂ÷¼öÁ¤Ã¼¼¶À¯(ìéó­â©ïÜô÷àéë«).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • visual deprivation
    ½Ã°¢Â÷´Ü
  • visual direction
    ½Ã¹æÇâ
  • visual directive line
    ½Ã¹æÇâ¼±(ãÊÛ°ú¾àÊ).
  • visual discrimination
    ½Ã°¢½Äº°
  • visual discriminatory acuity
    ½Ã°¢½Äº°µµ(ãÊÊÆãÛܬöô).
  • visual disorder =v. disturbance
    ½Ã°¢Àå¾Ö(¡­î¡äô)
  • visual disturbance
    ½Ã°¢Àå¾Ö.
  • visual efficiency
    ½ÃÈ¿À².
  • visual evoked potential
    ½ÃÀ¯¹ßÀüÀ§
  • visual evoked potential
    ½Ã°¢À¯¹ßÀüÀ§.
  • visual evoked response
    ½ÃÀ¯¹ß¹ÝÀÀ
  • visual fatigue
    ½Ã°¢ÇÇ·Î
  • visual field
    ½Ã¾ß(ãÊå¯)
  • visual field
    ½Ã¾ß(ãÊå¯).
  • visual field
    ½Ã¾ß(ãÊå¯)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 9
BVMOT Bender Visual-Motor Gestalt Test
CVF cardiovascular failure; central visual field; cervicovaginal fluid; cobra venom factor
DTVMI developmental test of visual motor integration
DTVP developmental test of visual perception
DVA developmental venous anomaly; distance visual acuity; duration of voluntary apnea; vindesine
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 9
SMC sensorimotor cortex
S1 somato-sensory cortex
TC temporal cortex
VLO ventrolateral orbital cortex
BVRT Benton Visual Retention Test
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
primary alcohol An alcohol characterised by the univalent radical, -CH2OH.
(05 Mar 2000)
primary aldosteronism An adrenocortical disorder caused by excessive secretion of aldosterone and characterised by headaches, nocturia, polyuria, fatigue, hypertension, potassium depletion, hypokalaemic alkalosis, hypervolaemia, and decreased plasma renin activity; may be associated with small benign adrenocortical adenomas.
Synonym: Conn's syndrome, idiopathic aldosteronism.
(05 Mar 2000)
primary amenorrhoea Amenorrhoea in which the menses have never occurred.
(05 Mar 2000)
primary amoebic meningoencephalitis An invasive, rapidly fatal cerebral infection by soil amoebae, chiefly Naegleria fowleri, found in man and other primates and experimentally in rodents; the disease is characterised by a high fever, neck rigidity, and symptoms associated with upper respiratory infection such as cough and nausea; although organisms have been cultured from various organs, the brain is the primary focus, especially the olfactory lobes and cerebral cortex, which are first attacked by the amoebae that enter from nasal mucosa through the cribriform plate; death usually occurs two to three days after onset of symptoms.
(05 Mar 2000)
primary amputation An amputation formerly performed during the period between trauma or incipient gangrene and suppuration.
Synonym: intrapyretic amputation, primary amputation.
(05 Mar 2000)
primary amyloidosis <immunology, nephrology> A disease which is characterised by the deposition of the fibrous protein amyloid in one or more locations within the body.
Amyloid deposition may occur in the kidney, brain, liver, heart, skin and lungs. A recognised complication is a restrictive cardiomyopathy.
(05 Mar 1998)
primary anaesthetic The compound that contributes most to loss of sensation when a mixture of anaesthetics is administered.
(05 Mar 2000)
primary antibody response <immunology> Antibodies made upon first exposure to an antigen, mostly of the class IgM.
(05 Mar 1998)
primary atelectasis <chest medicine, paediatrics> A nonexpansion of the lungs after birth is known as primary atelectasis.
Secondary atelectasis can occur at any age but is common in infants due to hyaline membrane disease. This form may also be seen in patients after surgery (general anaesthesia).
See: atelectasis.
(05 Mar 1998)
primary atypical pneumonia An acute systemic disease with involvement of the lungs, caused by Mycoplasma pneumoniae and marked by high fever, cough, relatively few physical signs, and scattered densities on X-rays; usually associated with development of cold agglutinins and antibodies to the bacteria.
Synonym: atypical pneumonia, Eaton agent pneumonia, mycoplasmal pneumonia.
(05 Mar 2000)
primary biliary cirrhosis <gastroenterology> A rare form of liver disease which results in the irreversible destruction of the liver and bile ducts. The cause is unknown, but is thought to be an autoimmune mechanism.
(06 Mar 1998)
primary brain tumour <neurology, oncology> May be subdivided into primary brain tumours and the more common, secondary brain tumours.
Primary brain tumours (for example astrocytoma, craniopharyngioma, glioma, ependymoma, neuroglioma, oligodendroglioma, glioblastoma multiforme, meningioma, medulloblastoma) arise from the uncontrolled proliferation of cells within the brain.
Secondary brain tumours occur from the spread of cancer into the brain from a distant cancerous organ (metastasis).
Common symptoms of a brain tumour include headache, nausea, vomiting, seizures, change in mentation, neurologic symptoms and loss of memory.
(06 Mar 1998)
primary brain vesicle Each of the three divisions of the early embryonic brain (prosencephalon, mesencephalon, and rhombencephalon).
Synonym: encephalic vesicle, primary brain vesicle.
(05 Mar 2000)
primary bronchus The main bronchus arising at the tracheal bifurcation and extending into the developing lung of the embryo.
(05 Mar 2000)
primary butyl alcohol Propylcarbinol, CH3CH2CH2CH2OH, the butyl alcohol of fermentation; isobutyl alcohol, isopropylcarbinol, 2-methyl-1-propanol, (CH3)2CHCH2OH; narcotic in high concentrations, secondary butyl alcohol, ethylmethylcarbinol, 2-butanol, CH3CH2CH(CH3)OH; and
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 9
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 9
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 9
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 9
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 9
ÅëÇÕ°Ë»ö ¿Ï·á